Pub. L. 119-60, div. A, tit. XVI, subtit. G, sec. 1691 (as amended)
COOPERATIVE THREAT REDUCTION FUNDS.
SEC. 1691. COOPERATIVE THREAT REDUCTION FUNDS.
(a) Funding Allocation.—Of the $282,830,000 authorized to be appropriated to the Department of Defense for fiscal year 2026 in section 301 and made available by the funding table in division D for the Department of Defense Cooperative Threat Reduction Program established under section 1321 of the Department of Defense Cooperative Threat Reduction Act (50 U.S.C. 3711), the following amounts may be obligated for the purposes specified:
(1) For delivery system threat reduction, $6,249,000.
(2) For chemical security and elimination, $25,292,000.
(3) For global nuclear security, $38,134,000.
(4) For biological threat reduction, $137,686,000.
(5) For proliferation prevention, $47,146,000.
(6) For activities designated as Other Assessments/Administration Costs, $28,323,000.
(b) Specification of Cooperative Threat Reduction Funds.—Funds appropriated pursuant to the authorization of appropriations in section 301 and made available by the funding
table in division D for the Department of Defense Cooperative Threat Reduction Program shall be available for obligation for fiscal years 2026, 2027, and 2028.
(c) Matters Concerning Biological Threat Reduction.—
(1) Reduction of highly pathogenic diseases.—In carrying out biological threat reduction activities pursuant to subsection (a)(4), the Secretary of Defense may not discontinue activities to reduce the threat of highly pathogenic diseases consistent with section 1321 of the Department of Defense Cooperative Threat Reduction Act (50 U.S.C. 3711), including through the provision of assistance to maintain existing pathogenic inventory and disease surveillance systems at existing locations developed under the Program.
(2) Report.—The Secretary shall ensure that the report submitted in fiscal year 2027 under section 1343 of the Department of Defense Cooperative Threat Reduction Act (50 U.S.C. 3743(c)(3)) includes a description of the activities and assistance described in paragraph (1) carried out during fiscal year 2026, as required by subsection (c)(3) of such section.